GGrantIndex
Sort

78,016 grants matching breast cancer

Retrospective NCI Phantom-Monte Carlo Dosimetry for Late Effects in Wilms Tumor

$543,223
John Andrew Kalapurakal · Northwestern University At Chicago · R01 · FY2021 · CA

Targeting lineage plasticity to inhibit basal-like breast cancer progression

$543,221
Wenjun Guo · Albert Einstein College Of Medicine · R01 · FY2025 · CA

Analysis of Tumor Dynamics in Progression and Metastasis

$543,220
University Of Pennsylvania · U01 · FY2005 · CA

Affinity-based Seurm Proteomics: Breast/Ovarian Cancer

$543,158
Martin W McIntosh · Fred Hutchinson Cancer Research Center · U01 · FY2009 · CA

Engineered Nanoformulation for Immune-modulation in Cancer

$543,107
Rajagopal Ramesh · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2023 · CA

Engineered ECM platforms to analyze progression in high grade serous ovarian cancer

$543,106
Pamela K Kreeger · University Of Wisconsin-Madison · R01 · FY2022 · CA

NOVEL BIOMARKERS FOR AROMATASE INHIBITOR THERAPY

$543,089
Matthew J Ellis · Washington University · R01 · FY2011 · CA

Nutrition Modulated Metabolism as a Disease Risk Factor

$543,074
Bruce S Kristal · Brigham And Women'S Hospital · R01 · FY2006 · CA

Understanding the Impact of Microscale and Nanoscale Heterogeneity and Resistance

$543,061
Joe W. Gray · Oregon Health & Science University · U54 · FY2019 · CA

BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma

$543,053
David R Jones · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA

Novel Nanopolymers to Inhibit Angiogenesis and Increase the Anti-tumor Immunity

$543,040
Manuel L Penichet · University Of California Los Angeles · R01 · FY2010 · CA

Enhancing Native American Participation in RT Trials

$543,034
Daniel G Petereit · Rapid City Regional Hospital · U56 · FY2007 · CA

Genetic epidemiology of cell division regulation in breast cancer

$542,988
Fergus Joseph Couch · Mayo Clinic Rochester · R01 · FY2008 · CA

Nitric Oxide as a Modifier of Oxidative Stress

$542,980
David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA

Strategies for Reaching and Impacting Our Communities Sustainably (NWP-ROCS Program)

$542,964
Rachel C Shelton · Columbia University Health Sciences · R01 · FY2024 · CA

Hawaii Minority-Based Clinical Community Oncology Program

$542,939
Jeffrey Lee Berenberg · University Of Hawaii At Manoa · U10 · FY2011 · CA

Optimizing HER2-targeting using RNA- and DNA-based predictive algorithms

$542,931
Lisa A Carey · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA

Impact of chromosomal instability on sensitivity to microtubule-targeting drugs in breast cancer

$542,912
Beth A Weaver · University Of Wisconsin-Madison · R01 · FY2021 · CA

Recruiting underserved populations into clinical trials with customizable media

$542,908
Charlene Anne Caburnay · Health Communication Impact, Llc · R44 · FY2015 · CA

64CU-DOTA-TRASTUZUMAB PET IMAGING IN WOMEN WITH HER2-OVEREXPRESSING BREAST CANCER

$542,873
Beckman Research Institute Of The City Of Hope · · FY2010 · Department of Defense

A HER-2/neu pulsed DC1 vaccine for patients with DCIS

$542,825
Brian Joseph Czerniecki · University Of Pennsylvania · R01 · FY2010 · CA

Reproduction, Lactation and Hormonal Factors in Breast Cancer Subtypes

$542,818
Julie R Palmer · Roswell Park Cancer Institute Corp · P01 · FY2014 · CA

Whitlockite nanoparticle-based immunotherapy for bone metastasis

$542,721
Shiladitya Sengupta · Brigham And Women'S Hospital · R01 · FY2021 · CA

Engineering ferritin degrader-encapsulated platelets for post-surgical TNBC treatment

$542,721
Quanyin Hu · University Of Wisconsin-Madison · R01 · FY2024 · EB

Engineering ferritin degrader-encapsulated platelets for post-surgical TNBC treatment

$542,721
Quanyin Hu · University Of Wisconsin-Madison · R01 · FY2025 · EB